FDA Warns Company Over Cancer Drug Claims

Statements in an advertisement ‘create a misleading impression that Anktiva ... can cure and even prevent all cancer,’ regulators said.

The U.S. Food and Drug Administration in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

A company called ImmunityBio misled the public by creating an impression that its cancer drug can cure all cancers, the Food and Drug Administration said in a newly released warning.

FDA officials on March 13 told ImmunityBio President and CEO Richard Adcock that they reviewed an advertisement for its drug Anktiva, which is approved for treating bladder cancer. The ad featured Dr. Patrick Soon-Shiong, ImmunityBio’s executive chairman, saying that “there’s an ability to actually create a cancer vaccine so that we can treat the tumor, and it doesn’t come back.”